Physician profile

David S Shaw

Obstetrics & Gynecology · Elk Grove Village, IL

NPI 1952484644

$251.18

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$26.02

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $43.49 2019
Pfizer INC. $38.72 2019
Daiichi Sankyo INC. $26.02 2023 Injectafer
Abbvie INC. $24.72 2019
Bayer Healthcare Pharmaceuticals INC. $21.34 2019
Lupin INC. $21.23 2019
Coopersurgical, INC. $18.13 2021
Roche Diagnostics Corporation $17.69 2019
Cranial Technologies, INC $15.57 2019
Hologic Sales and Service, LLC $13.20 2019
Dysis Medical, INC. $11.07 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David S Shaw

$251.18

in general payments reported 2019-2025

Years
2019-2023
Top company
Merck Sharp & Dohme LLC

https://glasscript.com/doctor/418860/david-s-shaw

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.